Healthcare Global Enterprises Ltd. · NSE:HCG
Healthcare Global Enterprises — Q2 & H1 FY20 Earnings Presentation
18 slides from Healthcare Global Enterprises's earnings presentation, Nov 7, 2019
Slide 1: Exchange filing cover letter for investor presentation
November 07, 2019 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Sub: Investor P
Slide 2: HealthCare Global Enterprises Limited Investor Presentation Q2 & H1-FY20
HealthCare Global Enterprises Limited Investor Presentation Q2 & H1-FY20 www.hcgel.com @2019 HCGEL – All Rights Reserved
Slide 3: Disclaimer
Disclaimer THIS PRESENTATION AND ITS CONTENTS ARE CONFIDENTIAL AND ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION WHERE SUCH DISTRIBUTION IS UNLAWFUL. This pr
Slide 4: Leadership in specialty healthcare
Leadership in specialty healthcare 3 www.hcgel.com
Slide 5: Contents
Contents Financial Highlights Operating Highlights Key Financial Project Updates Information www.hcgel.com
Slide 6: Financial Highlights: Q2-FY20
Financial Highlights: Q2-FY20 INR million except earnings per share • Q2’20 Revenue grew 13.5% y-o-y Q2-FY20 Q2-FY19 Growth Q2-FY20 Growth Period Ended Sep 30 As per AS 116 (y-o-y) w/o AS 116 (y-o-y) • HCG(1) centers: +13.2% Income from Operations 2,785 2,453 13.5% 2,785 13.5% • Milann(2) centers: +
Slide 7: Financial Highlights: H1-FY20
Financial Highlights: H1-FY20 INR million except earnings per share • H1’20 Revenue grew 16.0% y-o-y H1-FY20 H1-FY19 Growth H1-FY20 Growth Period Ended Sep 30 As per AS 116 (y-o-y) w/o AS 116 (y-o-y) • HCG(1) centers: +16.1% Income from Operations 5,473 4,719 16.0% 5,473 16.0% • Milann(2) centers: +
Slide 8: Revenue Mix: Q2-FY20
Revenue Mix: Q2-FY20 Revenue: HCG Centers: INR 2,785 Mn INR 2,597 Mn Gujarat 30% HCG (1) Karnataka centers 35% 1 (28%) 1 93% (38%) (93%) 1 Fertility (2) centers 7% North India Maharashtra (7%) 1 2% 14% (1%) 1 (14%) 1 Tamil Nadu A.P. East India (1) 21 comprehensive cancer centers, 3 multispecialty ho
Slide 9: HCG Centers: Q2-FY20 Revenues
HCG Centers: Q2-FY20 Revenues INR million • Strong growth continues at Growth Growth several existing and new centers Period Ended Sep 30 Q2-FY20 Q2-FY19 (y-o-y) H1-FY20 H1-FY19 (y-o-y) in Q2-FY20 • Bhavnagar: +44.7% y-o-y Karnataka 911 880 3.4% 1,797 1,723 4.3% Gujarat 773 653 18.4% 1,560 1,241 25.
Slide 10: Contents
Contents Financial Highlights Operating Highlights Key Financial Project Updates Information www.hcgel.com
Slide 11: HCG Centers: Q2-FY20 Operating Metrics
HCG Centers: Q2-FY20 Operating Metrics No. of Centers Beds Avg. Occupancy Rate Q2-FY20: Q2-FY20: • ARPOB for existing centers at INR 33,536 Q2-FY20: 2,031 43.1% against INR 30,306 in Q2-FY19 24 • Continuing reduction in ALOS to 2.03 on account Q2-FY19: of trend towards day care procedures and Q2-FY1
Slide 12: HCG Centers: Q2-FY20 Regional Highlights
HCG Centers: Q2-FY20 Regional Highlights ARPOB Revenue Operating Centers Beds AOR (INR/Day) (INR MN) EBITDA % Karnataka COE ARPOB of INR 60.3k with 26.6% operating EBITDA margin H1-FY20 COE ROCE improved from 26.1% 7 615 47.3% 35.6K 911 23.3% to 27.1% Focus on margin and returns optimization -
Slide 13: Milann: Implementing Strategic Initiatives
Milann: Implementing Strategic Initiatives Existing centers(1) New centers(2) Chandigarh Delhi Ahmedabad Q2-FY20 Q2-FY19 Growth New Registrations 1,506 1,394 8.0% IVF Cycles 579 510 13.5% Bangalore (5 centers) Revenue (INR Mn) 188 160 17.7% M S Ramaiah Indiranagar Shivananda Whitefield New Registr
Slide 14: Contents
Contents Financial Highlights Operating Highlights Key Financial Project Updates Information www.hcgel.com
Slide 15: Capital Expenditure and Net Debt
Capital Expenditure and Net Debt Capital Expenditure Net Debt INR Million INR Million Q2-FY20 Q1-FY20 30-Sep-19 30-Jun-19 HCG Centres Net Debt Existing Centres 65 44 Bank Debt(1) 5,151 4,626 (2) Expansions 88 65 Vendor Finance 1,123 1,350 New Centres 285 240 Capital Leases 563 563 438 349 Other Debt
Slide 16: Contents
Contents Financial Highlights Operating Highlights Key Financial Project Updates Information www.hcgel.com
Slide 17: Project Updates
Project Updates Additional 2 new HCG centers in FY2020 1 new Milann center launched in Q1 FY2019 Bed Project Cost Start Location Capacity (INR mn) Date Location Start Date Jaipur, Rajasthan 50 410 Q2-FY19 Delhi Q1-FY17 Bhavnagar, Gujarat NA 150 Q2-FY19 Chandigarh Q3-FY17 Nashik Phase II, 92 623 Q2-F
Slide 18: Thank You
THANK YOU For updates and specific queries, please visit www.hcgel.com or feel free to contact investors@hcgoncology.com © 2019 HealthCare Global Enterprises Limited., All Rights Reserved. HCG Logo is trademark of HealthCare Global Enterprises Limited In addition to Company data, data from market re
HealthCare Global Enterprises — Q2 & H1 FY20 Earnings Presentation on 6ix